Sign in

    Terrence A. Duffy

    Chairman and CEO at CME Group Inc
    Board
    Since November 2016
    Age
    66 years
    Education
    Has an academic background from the University of Wisconsin-Whitewater and earned honorary degrees including a Doctor of Public Service from Saint Xavier University in 2019 and a Doctor of Humane Letters from DePaul University in 2007.
    Tenure
    Began his association with CME in 1981 as a member, joined the board in 1995, and has served in key roles including Vice Chairman, Executive Chairman, Executive Chairman and President, and now as Chairman and CEO since November 2016.

    Also at CME Group Inc

    BTD
    Bryan T. Durkin
    Board Member
    JM
    Jonathan Marcus
    Senior Managing Director and General Counsel
    JW
    Julie Winkler
    Chief Commercial Officer (CCO)

    About

    Terrence A. Duffy is a 66-year-old executive who has demonstrated long-term leadership at CME Group, beginning his journey as a member in 1981 before joining the board of directors in 1995.

    Throughout his distinguished career at CME, he has held a series of progressively responsible roles—from serving as Vice Chairman to Executive Chairman and President, and ultimately assuming the role of Chairman and Chief Executive Officer in November 2016.

    In addition to his leadership at CME, his strategic vision has steered significant milestones, including the pioneering demutualization and public listing of the exchange, orchestrating key mergers and acquisitions, and spearheading the landmark Google Cloud partnership in 2021. His contributions also extend to public service, exemplified by his tenure on the Federal Retirement Thrift Investment Board from 2003 to 2013.

    $CME Performance Under Terrence A. Duffy

    Past Roles

    OrganizationRoleDate RangeDetails
    CME Group Executive Chairman and President May 2012 - November 2016 Stepped down upon promotion to Chairman and CEO
    CME Group Executive Chairman October 2006 - May 2012 N/A
    CME Group / CME Holdings Chairman of the Board April 2002 - October 2006 Oversaw board responsibilities for both entities
    CME Holdings Vice Chairman of the Board August 2001 - April 2002 N/A
    CME Group Vice Chairman of the Board 1998 - April 2002 N/A
    TDA Trading, Inc. President 1981 - 2002 Pre-CME experience

    External Roles

    OrganizationRoleDate RangeDetails
    Mayo Clinic Greater Chicago Leadership Council Co-Chair N/A N/A
    CME Group Foundation Vice Chairman N/A N/A
    Economic Club of Chicago Member N/A N/A
    Executives' Club of Chicago Member N/A N/A
    Chicago Council on Global Affairs (President's Circle) Member N/A N/A

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Base Salary$2,000,000 AnnualFixed annual salary for 2023.
    401(k) Company Contribution$9,900 AnnualContribution to 401(k) plan.
    Supplemental Plan Contributions (401(k) & Pension make-whole)$899,764 AnnualFor compensation exceeding statutory limits under Section 401(a)(17).
    Other Compensation$1,210 AnnualIncludes life insurance premiums with no additional supplemental life and long-term disability payments incurred.

    Performance Compensation

    Data from  FY 2023

    Performance Shares – TSR

    MetricDetailsCitation
    Performance MetricTSR relative to the S&P 500
    Performance Period2024-2026
    Threshold Shares7,253
    Target Shares14,505
    Maximum Shares29,010
    Payout ConditionsBelow 25th percentile: 0%; 25th percentile: 50%; 50th percentile: 100%; 75th percentile or above: 200% (capped at 100% if absolute TSR is negative)
    Grant DateSeptember 15, 2023
    Grant Date Fair Value$3,427,096
    Grant Date Stock Price$236.27
    Vesting ScheduleVests in full after the three-year performance period (2024-2026)

    Performance Shares – Net Income Margin (NIM)

    MetricDetailsCitation
    Performance MetricAbsolute Net Income Margin Performance
    Performance Period2024-2026
    Threshold Shares7,253
    Target Shares14,505
    Maximum Shares29,010
    Payout Conditions50% payout if at threshold, 100% if target met, 200% if maximum achieved
    Grant DateDecember 5, 2023
    Grant Date Fair Value$3,167,022
    Grant Date Stock Price$218.34
    Vesting ScheduleVests in full after the three-year performance period (2024-2026)

    Annual Equity Awards Summary

    • Composition: 50% performance shares (as detailed above) and 50% time-vested restricted stock.
    • Restricted Stock Vesting: Vests ratably over a four-year period.
    • Evaluation Period: Performance for both TSR and NIM components is evaluated over 2024-2026.
    • Additional Conditions: Performance shares are subject to adjustments based on actual results; for TSR, if the company’s absolute TSR is negative the maximum payout is capped at the target level (100%).